Patent directory · USPTO A61K / A61P
Patents matching “pd-”
81 pharma patents match "pd-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 81 pharmaceutical patents matching "pd-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2026107143
COMBINAISON DE DOSES FIXES D'ANTICORPS ANTI-FUCOSYL-GM1 ET D'ANTICORPS ANTI-PD-1 ET SES UTILISATIONS
granted -
WO 2026057739
POLYTHÉRAPIE COMPRENANT DES ANTICORPS ANTI-CTLA4 ET DES ANTICORPS ANTI-PD-1 POUR LE TRAITEMENT DU CANCER DE L'OVAIRE RÉSISTANT AU PLATINE
granted -
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
AR 133055
DOMINIOS VARIABLES ÚNICOS DE INMUNOGLOBULINA DIRIGIDOS A PD-L1
granted -
US 12391734
PD-1 homing endonuclease variants, compositions, and methods of use
granted -
US 12351633
PD-1 and PD-L1 binding agents
granted -
US 12338269
IL-2 superagonists in combination with anti-PD-1 antibodies
granted -
US 12325747
Human PD-L1 antibodies and methods of use therefor
granted -
US 12286483
Method of treating cancer using CD137 antibodies and PD-1 antagonists
granted -
TW 202515903
Anti-PD-1-based treatment before and after surgery
granted -
US 12269886
Tetravalent bispecific antibody against PD-1 and PD-L1
granted -
WO 2025040080
TRAITEMENT DU CANCER DE L'OESOPHAGE PAR ANTI-LAG3, ANTI-PD-1 ET CHIMIOTHÉRAPIE
granted -
US 12187799
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor
granted -
US 12168688
Antibodies and variants thereof against PD-L1
granted -
US 12134648
Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
granted -
US 12089575
Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins
granted -
US 12053534
Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging
granted -
US 12054556
Anti-PD-L1 antibody and use thereof
granted -
US 12054557
Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancer
granted -
US 12023355
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof
granted -
US 12018015
Methods and compositions for targeting PD-L1
granted -
US 11993655
Anti-PD-L1 antibody and use thereof
granted -
US 11981736
Antibodies specific to glycosylated PD-1 and methods of use thereof
granted